login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MorphoSys AG (MOR) Stock News
USA
- NASDAQ:MOR -
US6177602025
-
ADR
18.96
USD
+0.45 (+2.43%)
Last: 8/2/2024, 8:20:34 PM
18.96
USD
0 (0%)
After Hours:
8/2/2024, 8:20:34 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MOR Latest News, Press Relases and Analysis
All
Press Releases
10 months ago - By: Benzinga
Morpheus Launches $20 Million In Rewards For AI Compute Providers
a year ago - By: Halper Sadeh LLC
- Mentions:
SILK
AFBI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI on Behalf of Shareholders
a year ago - By: InvestorPlace
- Mentions:
ACWI
ACWX
GCT
NVS
...
3 Global Stocks to Buy to Escape the Volatility on Wall Street
2 years ago - By: Benzinga
MorphoSys: Q4 Earnings Insights
a year ago - By: MorphoSys AG
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
a year ago - By: Halper Sadeh LLC
- Mentions:
DM
SHCR
ALE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DM, SHCR, MOR, ALE on Behalf of Shareholders
a year ago - By: Halper Sadeh LLC
- Mentions:
ALLG
BEST
MGOL
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALLG, MOR, BEST, MGOL on Behalf of Shareholders
a year ago - By: Halper Sadeh LLC
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
a year ago - By: MorphoSys AG
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
a year ago - By: InvestorPlace
MOR Stock Earnings: MorphoSys Misses EPS, Misses Revenue for Q1 2024
a year ago - By: MorphoSys AG
MorphoSys AG Reports First Quarter 2024 Financial Results
1 years ago - By: MorphoSys AG
MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
2 years ago - By: MorphoSys AG
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2 years ago - By: InvestorPlace
- Mentions:
MRNA
MRK
INCY
ILMN
...
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
2 years ago - By: InvestorPlace
- Mentions:
NVAS
SAVA
INCY
NVS
Exit Now! 3 Biotech Stocks to Sell in February 2024
2 years ago - By: Seeking Alpha
- Mentions:
INCY
JMP cuts Incyte to market perform, cites need for acquisition (NASDAQ:INCY)
2 years ago - By: Seeking Alpha
- Mentions:
NVS
MorphoSys ADRs gain after definitive merger agreement with Novartis disclosed (NASDAQ:MOR)
2 years ago - By: Seeking Alpha
- Mentions:
NVS
Morphosys ADRs gain after definitive merger agreement with Novartis disclosed
2 years ago - By: Seeking Alpha
- Mentions:
NVS
MorphoSys drops amid speculation Novartis could walk from deal (NASDAQ:MOR)
2 years ago - By: Seeking Alpha
- Mentions:
NVS
MorphoSys ADRs drop amid speculation Novartis could walk from deal (NASDAQ:MOR)
2 years ago - By: Seeking Alpha
- Mentions:
NVS
MorphoSys ADRs drop amid speculation Novartis could walk from deal
2 years ago - By: Investor's Business Daily
- Mentions:
NVS
INCY
Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 Billion
2 years ago - By: Seeking Alpha
- Mentions:
INCY
NVS
Incyte buys global rights for tafasitamab from MorphoSys (NASDAQ:INCY)
Please enable JavaScript to continue using this application.